What: After shares sold off sharply in June following an update with investors, bargain hunters returned in July, sending shares in Pacific Biosciences (NASDAQ: PACB) 21.6% higher, according to S&P Global Market Intelligence .
What: After shares sold off sharply in June following an update with investors, bargain hunters returned in July, sending shares in Pacific Biosciences (NASDAQ: PACB) 21.6% higher, according to S&P Global Market Intelligence .